Regional Differences in Prescribing Patterns of Metamizole in Germany Based on Data from 70 Million Persons
Open Access
- 30 May 2020
- journal article
- research article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 17 (11) , 3892
Abstract
The non-opioid analgesic metamizole (dipyrone) is commonly used in Germany despite its narrow indications and market withdrawal from several countries. In this study we analyzed prescribing patterns of metamizole focusing on regional differences. The source of data was the “Information system for health care data” which includes data from the statutory health insurance funds for about 70 million Germans. We received aggregated data of individuals with at least one metamizole prescription in 2010 as well as the number of prescribed packages by age, sex, state and district along with the number of insured persons in each stratum. We calculated prescription prevalence stratified by age, sex, state and district. Among 68.4 million insured persons (mean age: 43.6 years; 53.0% female) 5.5 million received at least one metamizole prescription (8.1%, overall 12.2 million packages). Prevalence increased with age, and women received metamizole more often than men. In adults (total prevalence: 9.4%), levels varied between 7.0% (Saxony) and 11.1% (Schleswig-Holstein), whereas on a district level use ranged from 4.3% to 14.3%. In 2010, one of 12 individuals received metamizole at least once. Noticeable were the large regional variations which certainly cannot be explained by patient-related factors.Keywords
This publication has 33 references indexed in Scilit:
- Who gets dipyrone (metamizole) in Germany? Prescribing by age, sex and regionJournal of Clinical Pharmacy and Therapeutics, 2015
- Metamizole-induced agranulocytosis revisited: results from the prospective Berlin Case–Control Surveillance StudyEuropean Journal of Clinical Pharmacology, 2014
- Unterschiede in den soziodemografischen Merkmalen, der Gesundheit und Inanspruchnahme bei Kindern und Jugendlichen nach ihrer KrankenkassenzugehörigkeitBundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 2014
- Deficits in pain treatment in nursing homes in Germany: A cross‐sectional studyEuropean journal of pain, 2011
- Versorgung mit TNF-α-Blockern und regionale Unterschiede im Jahr 2010Zeitschrift für Rheumatologie, 2011
- Unterschiede in der Versichertenstruktur von Krankenkassen und deren Auswirkungen für die Versorgungsforschung: Ergebnisse des Bertelsmann-GesundheitsmonitorsDas Gesundheitswesen, 2011
- Update on the Incidence of Metamizole Sodium-Induced Blood Dyscrasias in PolandJournal of International Medical Research, 2010
- Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole)European Journal of Clinical Pharmacology, 2002
- Utilization pattern of metamizole in northern Sweden and risk estimates of agranulocytosisPharmacoepidemiology and Drug Safety, 2002
- Risks of Agranulocytosis and Aplastic AnemiaJAMA, 1986